Lactose (India) Ltd | 148 Cr. | 117 | 247/84.3 | 33.6 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
MPS Pharmaa Ltd | 3.96 Cr. | 2.07 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 4,702 Cr. | 432 | 440/192 | 105 | 22.8 | 0.16 % | 27.3 % | 21.7 % | 1.00 |
Gujarat Terce Laboratories Ltd | 36.4 Cr. | 49.0 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 30.0 Cr. | 20.4 | 29.1/17.0 | 31.2 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 60.2 Cr. | 80.0 | 134/78.9 | 15.9 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 52,543 Cr. | 1,862 | 2,286/1,275 | 39.4 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 319 Cr. | 14.0 | 23.8/10.8 | 19.4 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 744 Cr. | 1,575 | 1,575/635 | 31.7 | 299 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 107 Cr. | 21.3 | 32.0/15.0 | 32.6 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 775 Cr. | 263 | 449/219 | 7.42 | 123 | 0.95 % | 23.0 % | 24.9 % | 5.00 |
Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 14.2 Cr. | 5.70 | 9.28/2.11 | 8.06 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 381 Cr. | 393 | 477/112 | 61.4 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 4,816 Cr. | 1,107 | 1,584/1,045 | 47.0 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
Murae Organisor Ltd | 65.4 Cr. | 0.32 | 1.24/0.32 | 4.31 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 51.2 Cr. | 21.3 | 26.3/6.40 | 52.8 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 9.83 Cr. | 9.73 | 17.2/9.40 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
Coral Laboratories Ltd | 182 Cr. | 508 | 896/443 | 9.83 | 563 | 0.29 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 65.1 Cr. | 65.1 | 71.2/26.1 | 167 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
Concord Biotech Ltd | 16,016 Cr. | 1,531 | 2,452/1,345 | 44.8 | 173 | 0.70 % | 28.4 % | 21.4 % | 1.00 |
Colinz Laboratories Ltd | 19.0 Cr. | 41.5 | 88.7/37.9 | 39.6 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 15.0 Cr. | 5.98 | 5.98/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 18.6 Cr. | 124 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
Checkpoint Trends Ltd | 33.8 Cr. | 61.9 | 61.9/9.41 | 376 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
Chandra Bhagat Pharma Ltd | 31.0 Cr. | 41.1 | 80.0/0.00 | 43.7 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
Brawn Biotech Ltd | 6.00 Cr. | 20.0 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
Blue Jet Healthcare Ltd | 11,332 Cr. | 653 | 1,028/464 | 31.6 | 65.3 | 0.18 % | 39.8 % | 30.2 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 89.4 Cr. | 20.7 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 11.6 Cr. | 22.9 | 43.7/17.4 | 50.4 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
Mankind Pharma Ltd | 1,02,224 Cr. | 2,477 | 3,055/2,115 | 56.5 | 355 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
BDH Industries Ltd | 268 Cr. | 466 | 524/241 | 28.1 | 119 | 0.97 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 59.0 Cr. | 41.1 | 62.6/31.6 | 53.2 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
Aurobindo Pharma Ltd | 64,512 Cr. | 1,101 | 1,500/994 | 19.0 | 557 | 0.36 % | 14.2 % | 11.1 % | 1.00 |
Auro Laboratories Ltd | 138 Cr. | 221 | 303/170 | 200 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 795 Cr. | 79.4 | 123/74.0 | 17.2 | 32.5 | 1.89 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 40.4 Cr. | 31.0 | 50.0/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
Acutaas Chemicals Ltd | 13,483 Cr. | 1,647 | 1,666/727 | 60.2 | 160 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 3.77 Cr. | 0.57 | 1.45/0.56 | 75.4 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 245 Cr. | 32.0 | 68.0/30.0 | 13.0 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 9.48 Cr. | 16.2 | 25.5/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 140 Cr. | 5.93 | 6.57/2.82 | 325 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 63,336 Cr. | 29,805 | 37,000/25,260 | 43.6 | 1,992 | 1.59 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 7,557 Cr. | 834 | 972/550 | 28.4 | 220 | 0.60 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 249 Cr. | 87.9 | 89.8/31.3 | 59.9 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 4,618 Cr. | 1,523 | 1,577/535 | | 104 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 21,818 Cr. | 1,343 | 1,870/1,014 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 756 Cr. | 230 | 330/154 | 17.6 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
Venus Remedies Ltd | 604 Cr. | 452 | 568/270 | 12.9 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 3,277 Cr. | 465 | 950/455 | 26.2 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,649 Cr. | 1,167 | 1,663/991 | 23.4 | 768 | 0.86 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,21,304 Cr. | 3,584 | 3,790/2,886 | 60.1 | 224 | 0.89 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 1,152 Cr. | 125 | 317/98.0 | | 43.7 | 0.40 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,539 Cr. | 16.4 | 24.0/14.1 | 27.0 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
Cohance Lifesciences Ltd | 34,047 Cr. | 890 | 1,360/856 | 96.8 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
Suven Life Sciences Ltd | 4,356 Cr. | 192 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,02,872 Cr. | 1,679 | 1,924/1,547 | 35.1 | 301 | 0.95 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,665 Cr. | 598 | 886/441 | 109 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,598 Cr. | 293 | 325/175 | 37.0 | 75.9 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 341 Cr. | 1,127 | 1,680/956 | 19.7 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
Shilpa Medicare Ltd | 6,963 Cr. | 356 | 502/265 | 54.2 | 121 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
Sequent Scientific Ltd | 5,095 Cr. | 202 | 232/111 | 169 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 10,769 Cr. | 4,676 | 6,971/4,146 | 30.2 | 340 | 2.50 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,767 Cr. | 2,278 | 2,814/1,772 | 33.8 | 335 | 0.88 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 10,365 Cr. | 6,244 | 6,739/4,863 | 34.5 | 323 | 2.00 % | 47.8 % | 36.4 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 173 Cr. | 48.9 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 24,493 Cr. | 5,354 | 5,993/3,701 | 36.2 | 922 | 0.65 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 124 Cr. | 101 | 348/81.0 | 8.77 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
Panacea Biotec Ltd | 2,735 Cr. | 446 | 582/278 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,676 Cr. | 725 | 1,998/604 | 43.1 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
Neuland Laboratories Ltd | 20,888 Cr. | 16,281 | 18,100/10,060 | 158 | 1,188 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 302 Cr. | 13.5 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 14,798 Cr. | 826 | 1,505/660 | 8.72 | 425 | 0.73 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 2,635 Cr. | 48.1 | 91.7/41.7 | 28.4 | 21.1 | 0.42 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 8,023 Cr. | 177 | 359/162 | 22.9 | 54.4 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 111 Cr. | 70.2 | 130/65.5 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
Lyka Labs Ltd | 337 Cr. | 94.4 | 177/90.2 | 44.9 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
Lupin Ltd | 88,611 Cr. | 1,940 | 2,403/1,774 | 24.0 | 377 | 0.62 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,050 Cr. | 524 | 980/499 | 12.2 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
Laurus Labs Ltd | 48,587 Cr. | 900 | 944/440 | 95.4 | 84.6 | 0.13 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 901 Cr. | 868 | 1,235/596 | 20.7 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 150 Cr. | 69.6 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
Kopran Ltd | 802 Cr. | 166 | 329/154 | 23.0 | 107 | 1.81 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 652 Cr. | 373 | 500/265 | 23.3 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
Jubilant Pharmova Ltd | 17,201 Cr. | 1,080 | 1,310/802 | 35.4 | 393 | 0.46 % | 9.54 % | 9.55 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,518 Cr. | 1,693 | 1,998/1,303 | 38.7 | 221 | 0.92 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,465 Cr. | 220 | 328/175 | 34.4 | 36.1 | 1.14 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 32,634 Cr. | 1,286 | 1,758/1,168 | 36.5 | 274 | 0.31 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,863 Cr. | 97.5 | 127/57.5 | 27.2 | 57.5 | 0.82 % | 8.86 % | 6.13 % | 2.00 |
Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 745 Cr. | 101 | 134/67.2 | 33.8 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
Indoco Remedies Ltd | 2,631 Cr. | 285 | 355/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
Hikal Ltd | 2,959 Cr. | 240 | 465/236 | 46.8 | 102 | 0.58 % | 9.85 % | 7.38 % | 2.00 |
Hester Biosciences Ltd | 1,458 Cr. | 1,714 | 2,786/1,243 | 38.8 | 369 | 0.41 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,526 Cr. | 352 | 504/285 | 57.7 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
Granules India Ltd | 13,821 Cr. | 570 | 628/412 | 29.0 | 153 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 52,543 Cr. | 1,862 | 2,286/1,275 | 39.4 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 46,466 Cr. | 2,743 | 3,516/1,921 | 49.1 | 115 | 1.53 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 31,926 Cr. | 1,938 | 2,131/1,200 | 28.1 | 592 | 0.93 % | 15.8 % | 11.6 % | 1.00 |
FDC Ltd | 7,127 Cr. | 438 | 559/359 | 26.5 | 140 | 1.14 % | 15.9 % | 11.8 % | 1.00 |
ERIS Lifesciences Ltd | 21,745 Cr. | 1,596 | 1,910/1,097 | 56.2 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,04,819 Cr. | 1,256 | 1,406/1,020 | 18.4 | 402 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,365 Cr. | 278 | 322/169 | 36.7 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
Cipla Ltd | 1,27,433 Cr. | 1,578 | 1,612/1,310 | 23.6 | 386 | 0.82 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 15,108 Cr. | 1,988 | 2,641/1,551 | 26.7 | 347 | 0.30 % | 25.8 % | 22.7 % | 2.00 |
Brooks Laboratories Ltd | 361 Cr. | 122 | 203/95.6 | 178 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,607 Cr. | 152 | 191/105 | 15.1 | 99.7 | 0.33 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 64.6 Cr. | 39.7 | 75.0/39.0 | 23.2 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 47,616 Cr. | 356 | 406/291 | 132 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,805 Cr. | 1,788 | 2,215/1,430 | 39.4 | 195 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
Bal Pharma Ltd | 128 Cr. | 80.3 | 141/76.3 | 17.9 | 48.6 | 1.49 % | 10.1 % | 9.66 % | 10.0 |
Bafna Pharmaceuticals Ltd | 340 Cr. | 144 | 179/67.8 | 33.8 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
Astrazeneca Pharma India Ltd | 22,946 Cr. | 9,178 | 10,691/6,220 | 109 | 308 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,085 Cr. | 721 | 843/544 | 38.2 | 113 | 0.64 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 186 Cr. | 88.2 | 137/85.0 | 7.04 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
Alkem Laboratories Ltd | 66,735 Cr. | 5,582 | 6,250/4,492 | 29.4 | 1,002 | 0.81 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,449 Cr. | 939 | 1,188/725 | 31.1 | 264 | 1.17 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 452 Cr. | 792 | 1,540/763 | 71.9 | 688 | 0.63 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 30,466 Cr. | 2,438 | 3,220/2,022 | 32.8 | 303 | 1.15 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,504 Cr. | 313 | 509/258 | 25.6 | 127 | 1.66 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,759 Cr. | 518 | 575/312 | 26.6 | 136 | 0.19 % | 13.5 % | 13.0 % | 10.0 |
Industry Average | 19,828.94 Cr | 1,185.68 | | 50.47 | 194.07 | 0.34% | 16.24% | 14.95% | 6.10 |